Plain-English translation of NCT06192160 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether new combinations of medications—including , , and other drugs—can treat tuberculosis better and faster than the standard four-drug combination used today. The study will measure how quickly the bacteria in your lungs stop growing when you take these new treatments over 8 weeks, then continue with standard therapy for 18 more weeks.
Standard tuberculosis treatment takes months and can have difficult side effects. Researchers hope these new medication combinations will work faster and be easier to tolerate, giving patients a better chance at a complete cure.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to take either the standard tuberculosis medications or one of the new medication combinations for the first 8 weeks. After that, everyone switches to the standard treatment for 18 more weeks. During the study, you will have regular clinic visits for blood tests, sputum samples, and check-ups to monitor how well the treatment is working and whether you have any side effects. The entire study lasts about 52 weeks from start to finish.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
Botswana
Brazil
Haiti